Aspirin does not reduce the risk of heart diabetik

The researchers from Kumamoto University of Japan to find, low-dose aspirin does not reduce the risk of a meaningful cardiovascular disease in patients with type 2 diabetes. According to the researchers, aspirin is not a means to reduce the combination of fatal coronary and cerebrovascular fatal.

In the study, Japanese Primary Prevention of atherosclerosis with Aspirin for Diabetes, the researchers examined whether low-dose aspirin to prevent atherosclerosis that stricture, or stiffening arteries due to plaque dump on patients with type 2 diabetes.

From December 2002 to April 2008, 2,539 patients with type 2 diabetes and do not have a history of atherosclerosis from 163 institutions in Japan, occurred 154 cases of atherosclerosis. 68 from the aspirin group and 86 from non-aspirin group.
In the 1,363 patients age 65 years or older, aspirin group consisted of 719 persons and non-aspirin group 644 people. Case in atherosclerosis means lower in the aspirin group. Or 45 cases in the aspirin group and 59 cases in non-aspirin group.
From the 1,176 patients under age 65, the difference between the two groups are not meaningful. The findings published in the Journal of the American Medical Association and presented at the American Heart Association meeting in New Orleans.